Patents by Inventor Pamela Douglass

Pamela Douglass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230203571
    Abstract: The disclosed disclosure is related to methods, compositions, and kits for targeting Adenovirus, Metapneumovirus, and/or Rhinovirus nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers. Methods include uniplex and multiplex amplification and detection reactions.
    Type: Application
    Filed: December 27, 2022
    Publication date: June 29, 2023
    Inventors: Mehrdad R. MAJLESSI, Ankur SHAH, Amber HILLIUS, Pamela DOUGLASS, Daniel KOLK
  • Publication number: 20230203572
    Abstract: The disclosed disclosure is related to methods, compositions, and kits for targeting Adenovirus, Metapneumovirus, and/or Rhinovirus nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers. Methods include uniplex and multiplex amplification and detection reactions.
    Type: Application
    Filed: December 27, 2022
    Publication date: June 29, 2023
    Inventors: Mehrdad R. MAJLESSI, Ankur SHAH, Amber HILLIUS, Pamela DOUGLASS, Daniel KOLK
  • Publication number: 20230087588
    Abstract: The disclosed disclosure is related to methods, compositions, and kits for targeting Adenovirus, Metapneumovirus, and/or Rhinovirus nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers. Methods include uniplex and multiplex amplification and detection reactions.
    Type: Application
    Filed: August 17, 2022
    Publication date: March 23, 2023
    Inventors: Mehrdad R. MAJLESSI, Ankur Shah, Amber Hillius, Pamela Douglass, Daniel Kolk
  • Publication number: 20220372563
    Abstract: The disclosed disclosure is related to methods, compositions, and kits for targeting Adenovirus, Metapneumovirus, and/or Rhinovinis nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers. Methods include uniplex and multiplex amplification and detection reactions.
    Type: Application
    Filed: June 7, 2022
    Publication date: November 24, 2022
    Inventors: Mehrdad R. MAJLESSI, Ankur SHAH, Amber HILLIUS, Pamela DOUGLASS, Daniel KOLK
  • Patent number: 11384387
    Abstract: The disclosed disclosure is related to methods, compositions, and kits for targeting Adenovirus, nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers. Methods include uniplex and multiplex amplification and detection reactions.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: July 12, 2022
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Mehrdad R. Majlessi, Ankur Shah, Amber Hillius, Pamela Douglass, Daniel Kolk
  • Publication number: 20210040541
    Abstract: Compositions, methods, kits, and uses are provided for detecting or quantifying an Human Parainfluenza virus 1 (HPIV-1), HPIV-2, HPIV-3, and/or HPIV-4 nucleic acid, e.g., using nucleic acid amplification and hybridization assays. In some embodiments, the compositions, methods, kits, and uses target the HN gene of HPIV-1, HPIV-2, and/or HPIV-3 and/or the NP gene of HPIV-4.
    Type: Application
    Filed: October 16, 2020
    Publication date: February 11, 2021
    Applicant: Gen-Probe Incorporated
    Inventors: Mehrdad Majlessi, Pamela Douglass, Daniel Kolk
  • Patent number: 10844425
    Abstract: Compositions, methods, kits, and uses are provided for detecting or quantifying an Human Parainfluenza virus 1 (HPIV-1), HPIV-2, HPIV-3, and/or HPIV-4 nucleic acid, e.g., using nucleic acid amplification and hybridization assays. In some embodiments, the compositions, methods, kits, and uses target the HN gene of HPIV-1, HPIV-2, and/or HPIV-3 and/or the NP gene of HPIV-4.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: November 24, 2020
    Assignee: Gen-Probe Incorporated
    Inventors: Mehrdad Majlessi, Pamela Douglass, Daniel Kolk
  • Publication number: 20200263242
    Abstract: The disclosed disclosure is related to methods, compositions, and kits for targeting Adenovirus, Metapneumovirus, and/or Rhinovirus nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers. Methods include uniplex and multiplex amplification and detection reactions.
    Type: Application
    Filed: March 23, 2018
    Publication date: August 20, 2020
    Applicant: GEN-PROBE INCORPORATED
    Inventors: Mehrdad R. MAJLESSI, Ankur SHAH, Amber HILLIUS, Pamela DOUGLASS, Daniel KOLK
  • Publication number: 20200048721
    Abstract: This disclosure concerns amplification primers, hybridization assay probes, compositions containing such primers and probes, and associated reagents, kits, and methods, that can be used to analyze samples for the presence of Influenza A virus, Influenza B virus, Respiratory Syncytial Virus A, and/or Respiratory Syncytial Virus B target nucleic acids.
    Type: Application
    Filed: March 23, 2018
    Publication date: February 13, 2020
    Applicant: GEN-PROBE INCORPORATED
    Inventors: Matthias JOST, Pamela DOUGLASS, Daniel P. KOLK, Mehrdad R. MAJLESSI
  • Publication number: 20180274012
    Abstract: Compositions, methods, kits, and uses are provided for detecting or quantifying an Human Parainfluenza virus 1 (HPIV-1), HPIV-2, HPIV-3, and/or HPIV-4 nucleic acid, e.g., using nucleic acid amplification and hybridization assays. In some embodiments, the compositions, methods, kits, and uses target the HN gene of HPIV-1, HPIV-2, and/or HPIV-3 and/or the NP gene of HPIV-4.
    Type: Application
    Filed: March 23, 2018
    Publication date: September 27, 2018
    Applicant: Gen-Probe Incorporated
    Inventors: Mehrdad Majlessi, Pamela Douglass, Daniel Kolk